je.st
news
Teva gains standing to challenge Mylan poison pill
2015-06-19 15:52:18| Biotech - Topix.net
Teva Pharmaceutical Industries Ltd. has acquired a 4.61 percent stake in generic drug rival Mylan N.V., giving Teva standing to challenge Mylan's Dutch poison-pill defense against a hostile takeover.
Tags: challenge
standing
gains
pill
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||